We recently compiled a list of the 10 Important AI News and Ratings for Today. In this article, we are going to take a look ...

Corporate America just kicked off a new quarterly earnings season. Over the next few weeks, hundreds of companies will report ...

EyePoint's Duravyu, a potential "best-in-class" therapy for Wet AMD and DME, could disrupt the market with fewer injections compared to Eylea. Read more here.

Cathie Wood, chief of Ark Investment Management, believes in tech stocks that will have a disruptive impact. She isn’t afraid to buy them on the way down — or up. Sometimes her strategy works: The ...

AMD (AMD) shares rallied close to $120 again to erase more than half of their DeepSeek-inspired losses as analysts stuck to ...

In terms of liquidity and interest, the mean open interest for Advanced Micro Devices options trades today is 8163.78 with a total volume of 55,747.00.

Shares of semiconductor company Advanced Macro Devices (AMD) have declined more than 34% over the past year, in contrast to the 98% rally in ...

Opthea's lead compound, sozinibercept, targets VEGF-C/D and is in Phase 3 trials for wet AMD. Read more to see why I'm neutral on OPT stock.

Nvidia’s AI leadership remains intact, despite DeepSeek concerns. Read why NVDA stock’s steep drop represents a great ...

Despite negative revision trends, AMD is an attractive buy heading into its Q4 2024 report due to improving fundamentals and ...

We recently compiled a list of the Jim Cramer Discussed These 11 Stocks Before The DeepSeek Sell-Off. In this article, we are going to take a look at where Advanced Micro Devices, Inc.